A team of researchers from Luxembourg has developed a new AI algorithm trained to diagnose Type 2 diabetes by listening to a person’s voice—a novel, noninvasive, and possibly cheap screening methodology that could change the lives of many. This breakthrough was possible with the help of the Luxembourg Institute of Health, guided by Abir Elbeji and Dr. Guy Fagherazzi. They used high-end machine learning, which identified a subtle change of voice— a biomarker-characteristic of this pathology, which makes it distinct from other technologies currently in use.